EDITORIAL

Consumer Engagement
David B. Nash, MD, MBA

A

s many regular readers of P&T
know, I often scan the literature
of reports from the private sector
and select some of these for my editorials. Recently, a report from the national
BlueCross BlueShield Association
(BCBSA) crossed my desk and appears
to have important implications for P&T
committee members in different sectors.
Published at the end of 2006, the report was entitled Consumer Preferences
and Usage of Healthcare Information.
BCBSA conducted an online survey of
more than 1,600 health insurance members from what the “Blues” call the
Knowledge Networks Consumer Panel.
Consumers were asked about the information they had used or would use to
support the following four key health
care decisions:
•
•
•
•

selecting a primary care provider
selecting a specialist
selecting a hospital or clinic
selecting a treatment option

The responders were asked about the
types of information they had searched
and used based on whether they had
made any of these decisions concerning
health care during the past year. Those
with no experience in any of these areas
were asked to predict their preferred
source of information if they had to make
these types of decisions. (I understood
this to mean that the Blues were interested in learning how their own members use the Web to access health care
information.)
I was particularly interested in the
fourth question (selecting a treatment
option), because I thought that this topic
had the greatest implication for P&T
committees. According to the survey,
more than 86% of consumers sought at
least one form of information about the
quality of the treatment when deciding
about therapy options. Consumers primarily sought general background information about each option; they also
wanted to learn about the rates of complications and the success rates of vari-
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ous alternatives and of the health care
providers administering the treatment.
So far, no big surprises.
Of greater interest to me were the specific details involved in selecting a therapeutic option. Of those consumers who
selected a treatment option, they considered complication rates, treatment success rates, and information about clinical
trials to be more important than the
average costs of treatment. In my view,
this is an important finding, because this
survey represents the first time that I’ve
seen documentation of a nationwide
subtle shift by consumers toward trans-

. . . the way in which
information about costs
and the quality of health
care is presented to
consumers is critical to
effective decision-making.
parency and away from simple cost information.
In other aspects of information-seeking behavior, such as selecting a primary
care provider, a specialist, or a hospital,
similar results emerged. It appeared, at
least in this survey, that patients were
doing more digging for facts and were
embracing the concept of transparency.
From this report, I realized that the
way in which information about costs
and the quality of health care is presented to consumers is critical to effective decision-making. Usage of the Internet for obtaining health information was
significantly greater among women and
among more frequent users of health
care resources. Women were far more
likely than men (50% vs. 34%) to use the
Internet to search for health care information.
I found other aspects of the survey
counterintuitive. For instance, some con-

sumers claimed that they could not find
sufficiently detailed information on treatments used in specific hospitals. This is
puzzling, because Medicare, of course,
has posted facts about every hospital for
the past two years on a special Web site
(www.hospitalcompare.gov). This gap
continues to remind me that we have a
long way to go in engaging consumers,
male and female, in all socioeconomic
strata, in the need to improve transparency.
In conclusion, the BCBSA repor t
breaks new ground. It helped me understand how consumers are currently
processing all of the available information that resides on the Web. The question for P&T committees is this: How will
your organization present itself on the
Web in terms of clinical outcomes, treatment options, information about primary
care providers, and the like?
I can envision the day when the formularies of each organization will be more
readily available for consumer scrutiny.
I can also visualize a time when detailed
results of complex clinical trials will be
evaluated and synthesized for consumers
and posted by integrated delivery systems, hospitals, and managed care organizations. Reports such as this survey
help us to comprehend which topics our
consumers are thinking about and how
they go about learning more about our
own daily work as health care professionals.
Copies of this report are available at
www.bcbs.com/issues/transparency/
research/consumer-transparency.html.
You can also call David Pizza at Strategic
Services, BlueCross BlueShield headquarters, in Chicago at 312–297–6493.
As usual, I am interested in your views.
You can reach me at my e-mail address,
david.nash@jefferson.edu. 

